Testing effectiveness (Phase 2)Ended earlyNCT04408183
What this trial is testing
GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)
Who this might be right for
SARS-CoV 2Infection
GeneOne Life Science, Inc. 184
Showing 20 of 0 results